{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T20:33:16Z","timestamp":1774125196685,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Microbiol"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1038\/nrmicro977","type":"journal-article","created":{"date-parts":[[2004,10,19]],"date-time":"2004-10-19T19:01:40Z","timestamp":1098212500000},"page":"721-726","source":"Crossref","is-referenced-by-count":91,"title":["Antitoxins: novel strategies to target agents of bioterrorism"],"prefix":"10.1038","volume":"2","author":[{"given":"G. Jonah A.","family":"Rainey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A. T.","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BFnrmicro977_CR1","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1146\/annurev.pharmtox.44.101802.121554","volume":"44","author":"LL Simpson","year":"2004","unstructured":"Simpson, L. L. Identification of the major steps in botulinum toxin action. Annu. Rev. Pharmacol. Toxicol. 44, 167\u2013193 (2004).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"BFnrmicro977_CR2","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2165\/00139709-200322010-00006","volume":"22","author":"MJ Lord","year":"2003","unstructured":"Lord, M. J. et al. Ricin. Mechanisms of cytotoxicity. Toxicol. Rev. 22, 53\u201364 (2003).","journal-title":"Toxicol. Rev."},{"key":"BFnrmicro977_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1146\/annurev.cellbio.19.111301.140655","volume":"19","author":"RJ Collier","year":"2003","unstructured":"Collier, R. J. & Young, J. A. Anthrax toxin. Annu. Rev. Cell Dev. Biol. 19, 45\u201370 (2003).","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"BFnrmicro977_CR4","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1146\/annurev.micro.55.1.647","volume":"55","author":"M Mock","year":"2001","unstructured":"Mock, M. & Fouet, A. Anthrax. Annu. Rev. Microbiol. 55, 647\u2013671 (2001).","journal-title":"Annu. Rev. Microbiol."},{"key":"BFnrmicro977_CR5","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S1369-5274(02)00359-4","volume":"5","author":"PH Gilligan","year":"2002","unstructured":"Gilligan, P. H. Therapeutic challenges posed by bacterial bioterrorism threats. Curr. Opin. Microbiol. 5, 489\u2013495 (2002).","journal-title":"Curr. Opin. Microbiol."},{"key":"BFnrmicro977_CR6","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1172\/JCI17991","volume":"112","author":"M Moayeri","year":"2003","unstructured":"Moayeri, M., Haines, D., Young, H. A. & Leppla, S. H. Bacillus anthracis lethal toxin induces TNF-\u03b1-independent hypoxia-mediated toxicity in mice. J. Clin. Invest. 112, 670\u2013682 (2003).","journal-title":"J. Clin. Invest."},{"key":"BFnrmicro977_CR7","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1128\/IAI.72.1.430-439.2004","volume":"72","author":"JE Kirby","year":"2004","unstructured":"Kirby, J. E. Anthrax lethal toxin induces human endothelial cell apoptosis. Infect. Immun. 72, 430\u2013439 (2004).","journal-title":"Infect. Immun."},{"key":"BFnrmicro977_CR8","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1126\/science.1073163","volume":"297","author":"JM Park","year":"2002","unstructured":"Park, J. M., Greten, F. R., Li, Z. W. & Karin, M. Macrophage apoptosis by anthrax lethal factor through p38 MAP kinase inhibition. Science 297, 2048\u20132051 (2002).","journal-title":"Science"},{"key":"BFnrmicro977_CR9","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1083\/jcb.200211018","volume":"160","author":"L Abrami","year":"2003","unstructured":"Abrami, L., Liu, S., Cosson, P., Leppla, S. H. & van der Goot, F. G. Anthrax toxin triggers endocytosis of its receptor via a lipid-raft-mediated clathrin-dependent process. J. Cell Biol. 160, 321\u2013328 (2003).","journal-title":"J. Cell Biol."},{"key":"BFnrmicro977_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/n35101999","volume":"414","author":"KA Bradley","year":"2001","unstructured":"Bradley, K. A., Mogridge, J., Mourez, M., Collier, R. J. & Young, J. A. Identification of the cellular receptor for anthrax toxin. Nature 414, 225\u2013229 (2001).","journal-title":"Nature"},{"key":"BFnrmicro977_CR11","doi-asserted-by":"publisher","first-page":"5170","DOI":"10.1073\/pnas.0431098100","volume":"100","author":"HM Scobie","year":"2003","unstructured":"Scobie, H. M., Rainey, G. J., Bradley, K. A. & Young, J. A. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor. Proc. Natl Acad. Sci. USA 100, 5170\u20135174 (2003). Identified CMG2 as an anthrax toxin receptor and demonstrated the ability of a soluble form of this receptor to effectively neutralize PA at a 3:1 molar ratio.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrmicro977_CR12","doi-asserted-by":"publisher","first-page":"49342","DOI":"10.1074\/jbc.M307900200","volume":"278","author":"KA Bradley","year":"2003","unstructured":"Bradley, K. A. et al. Binding of anthrax toxin to its receptor is similar to \u03b1-integrin\u2013ligand interactions. J. Biol. Chem. 278, 49342\u201349347 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnrmicro977_CR13","doi-asserted-by":"publisher","first-page":"30865","DOI":"10.1074\/jbc.M403945200","volume":"279","author":"A Rummel","year":"2004","unstructured":"Rummel, A., Karnath, T., Henke, T., Bigalke, H. & Binz, T. Synaptotagmins I and II act as nerve cell receptors for botulinum neurotoxin G. J. Biol. Chem. 279, 30865\u201330870 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnrmicro977_CR14","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1083\/jcb.200305098","volume":"162","author":"M Dong","year":"2003","unstructured":"Dong, M. et al. Synaptotagmins I and II mediate entry of botulinum neurotoxin B into cells. J. Cell Biol. 162, 1293\u20131303 (2003). Synaptotagmins I and II are identified as receptors for BoNT and soluble forms of these receptors are able to block intoxication  in vivo.","journal-title":"J. Cell Biol."},{"key":"BFnrmicro977_CR15","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/364827a0","volume":"364","author":"MF Schmid","year":"1993","unstructured":"Schmid, M. F., Robinson, J. P. & DasGupta, B. R. Direct visualization of botulinum neurotoxin-induced channels in phospholipid vesicles. Nature 364, 827\u2013830 (1993).","journal-title":"Nature"},{"key":"BFnrmicro977_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2165\/00139709-200322010-00007","volume":"22","author":"SM Bradberry","year":"2003","unstructured":"Bradberry, S. M., Dickers, K. J., Rice, P., Griffiths, G. D. & Vale, J. A. Ricin poisoning. Toxicol. Rev. 22, 65\u201370 (2003).","journal-title":"Toxicol. Rev."},{"key":"BFnrmicro977_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1476-8518-2-5","volume":"2","author":"R Sawada-Hirai","year":"2004","unstructured":"Sawada-Hirai, R. et al. Human anti-anthrax protective antigen neutralizing monoclonal antibodies derived from donors vaccinated with anthrax vaccine adsorbed. J. Immune Based Ther. Vaccines 2, 5 (2004).","journal-title":"J. Immune Based Ther. Vaccines"},{"key":"BFnrmicro977_CR18","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nbt0602-597","volume":"20","author":"JA Maynard","year":"2002","unstructured":"Maynard, J. A. et al. Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity. Nature Biotechnol. 20, 597\u2013601 (2002). Neutralizing antibodies against anthrax toxin PA undergo affinity maturation and their efficacy against toxin challenges  in vivo  are demonstrated.","journal-title":"Nature Biotechnol."},{"key":"BFnrmicro977_CR19","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/nbt891","volume":"21","author":"MA Wild","year":"2003","unstructured":"Wild, M. A. et al. Human antibodies from immunized donors are protective against anthrax toxin in vivo. Nature Biotechnol. 21, 1305\u20131306 (2003).","journal-title":"Nature Biotechnol."},{"key":"BFnrmicro977_CR20","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3233\/HAB-2003-12404","volume":"12","author":"P Zhao","year":"2003","unstructured":"Zhao, P., Liang, X., Kalbfleisch, J., Koo, H. M. & Cao, B. Neutralizing monoclonal antibody against anthrax lethal factor inhibits intoxication in a mouse model. Hum. Antibodies 12, 129\u2013135 (2003).","journal-title":"Hum. Antibodies"},{"key":"BFnrmicro977_CR21","doi-asserted-by":"publisher","first-page":"11346","DOI":"10.1073\/pnas.172229899","volume":"99","author":"A Nowakowski","year":"2002","unstructured":"Nowakowski, A. et al. Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody. Proc. Natl Acad. Sci. USA 99, 11346\u201311350 (2002). Demonstrated that, although single monoclonal antibodies do not exhibit strong toxin neutralizing activity, a cocktail of three antibodies to non-overlapping epitopes is an effective antitoxin  in vivo.","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrmicro977_CR22","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1089\/hyb.1994.13.417","volume":"13","author":"PV Lemley","year":"1994","unstructured":"Lemley, P. V., Amanatides, P. & Wright, D. C. Identification and characterization of a monoclonal antibody that neutralizes ricin toxicity in vitro and in vivo. Hybridoma 13, 417\u2013421 (1994).","journal-title":"Hybridoma"},{"key":"BFnrmicro977_CR23","first-page":"505","volume":"18","author":"TL Furukawa-Stoffer","year":"1999","unstructured":"Furukawa-Stoffer, T. L., Mah, D. C., Cherwonogrodzky, J. W. & Weselake, R. J. A novel biological-based assay for the screening of neutralizing antibodies to ricin. Hybridoma 18, 505\u2013511 (1999).","journal-title":"Hybridoma"},{"key":"BFnrmicro977_CR24","doi-asserted-by":"publisher","first-page":"23349","DOI":"10.1074\/jbc.M401292200","volume":"279","author":"DJ Wigelsworth","year":"2004","unstructured":"Wigelsworth, D. J. et al. Binding stoichiometry and kinetics of the interaction of a human anthrax toxin receptor, CMG2, with protective antigen. J. Biol. Chem. 279, 23349\u201323356 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnrmicro977_CR25","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1128\/IAI.72.1.602-605.2004","volume":"72","author":"MS Sarac","year":"2004","unstructured":"Sarac, M. S., Peinado, J. R., Leppla, S. H. & Lindberg, I. Protection against anthrax toxemia by hexa-d\u2013arginine in vitro and in vivo. Infect. Immun. 72, 602\u2013605 (2004).","journal-title":"Infect. Immun."},{"key":"BFnrmicro977_CR26","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nbt1001-958","volume":"19","author":"M Mourez","year":"2001","unstructured":"Mourez, M. et al. Designing a polyvalent inhibitor of anthrax toxin. Nature Biotechnol. 19, 958\u2013961 (2001).","journal-title":"Nature Biotechnol."},{"key":"BFnrmicro977_CR27","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1126\/science.109563","volume":"292","author":"BR Sellman","year":"2001","unstructured":"Sellman, B. R., Mourez, M. & Collier, R. J. Dominant-negative mutants of a toxin subunit: an approach to therapy of anthrax. Science 292, 695\u2013697 (2001). Identified a dominant-negative mutant of anthrax toxin PA that allows formation of toxin complexes, but blocks pore formation and toxin translocation.","journal-title":"Science"},{"key":"BFnrmicro977_CR28","doi-asserted-by":"publisher","first-page":"40075","DOI":"10.1074\/jbc.M306466200","volume":"278","author":"F Tonello","year":"2003","unstructured":"Tonello, F., Ascenzi, P. & Montecucco, C. The metalloproteolytic activity of the anthrax lethal factor is substrate-inhibited. J. Biol. Chem. 278, 40075\u201340078 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnrmicro977_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/nsmb708","volume":"11","author":"BE Turk","year":"2004","unstructured":"Turk, B. E. et al. The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor. Nature Struct. Mol. Biol. 11, 60\u201366 (2004).","journal-title":"Nature Struct. Mol. Biol."},{"key":"BFnrmicro977_CR30","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1038\/418386a","volume":"418","author":"F Tonello","year":"2002","unstructured":"Tonello, F., Seveso, M., Marin, O., Mock, M. & Montecucco, C. Screening inhibitors of anthrax lethal factor. Nature 418, 386 (2002).","journal-title":"Nature"},{"key":"BFnrmicro977_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0014-5793(98)01041-2","volume":"435","author":"JJ Schmidt","year":"1998","unstructured":"Schmidt, J. J., Stafford, R. G. & Bostian, K. A. Type A botulinum neurotoxin proteolytic activity: development of competitive inhibitors and implications for substrate specificity at the S1\u2032 binding subsite. FEBS Lett. 435, 61\u201364 (1998).","journal-title":"FEBS Lett."},{"key":"BFnrmicro977_CR32","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/S0014-5793(02)03738-9","volume":"532","author":"JJ Schmidt","year":"2002","unstructured":"Schmidt, J. J. & Stafford, R. G. A high-affinity competitive inhibitor of type A botulinum neurotoxin protease activity. FEBS Lett. 532, 423\u2013426 (2002).","journal-title":"FEBS Lett."},{"key":"BFnrmicro977_CR33","doi-asserted-by":"publisher","first-page":"4648","DOI":"10.1021\/jm0300680","volume":"46","author":"C Anne","year":"2003","unstructured":"Anne, C. et al. Development of potent inhibitors of botulinum neurotoxin type B. J. Med. Chem. 46, 4648\u20134656 (2003).","journal-title":"J. Med. Chem."},{"key":"BFnrmicro977_CR34","doi-asserted-by":"publisher","first-page":"4937","DOI":"10.1074\/jbc.275.7.4937","volume":"275","author":"JR Hesselberth","year":"2000","unstructured":"Hesselberth, J. R., Miller, D., Robertus, J. & Ellington, A. D. In vitro selection of RNA molecules that inhibit the activity of ricin A chain. J. Biol. Chem. 275, 4937\u20134942 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnrmicro977_CR35","doi-asserted-by":"publisher","first-page":"6845","DOI":"10.1021\/bi010499p","volume":"40","author":"KS Tanaka","year":"2001","unstructured":"Tanaka, K. S. et al. Ricin A-chain inhibitors resembling the oxacarbenium ion transition state. Biochemistry 40, 6845\u20136851 (2001).","journal-title":"Biochemistry"},{"key":"BFnrmicro977_CR36","doi-asserted-by":"publisher","first-page":"4923","DOI":"10.1021\/bi0498499","volume":"43","author":"S Roday","year":"2004","unstructured":"Roday, S. et al. Inhibition of ricin A-chain with pyrrolidine mimics of the oxacarbenium ion transition state. Biochemistry 43, 4923\u20134933 (2004).","journal-title":"Biochemistry"},{"key":"BFnrmicro977_CR37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/nsmb711","volume":"11","author":"RG Panchal","year":"2004","unstructured":"Panchal, R. G. et al. Identification of small molecule inhibitors of anthrax lethal factor. Nature Struct. Mol. Biol. 11, 67\u201372 (2004).","journal-title":"Nature Struct. Mol. Biol."},{"key":"BFnrmicro977_CR38","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/nbt973","volume":"22","author":"DH Min","year":"2004","unstructured":"Min, D. H., Tang, W. J. & Mrksich, M. Chemical screening by mass spectrometry to identify inhibitors of anthrax lethal factor. Nature Biotechnol. 22, 717\u2013723 (2004).","journal-title":"Nature Biotechnol."},{"key":"BFnrmicro977_CR39","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1038\/sj.embor.7400118","volume":"5","author":"I Dell'Aica","year":"2004","unstructured":"Dell'Aica, I. et al. Potent inhibitors of anthrax lethal factor from green tea. EMBO Rep. 5, 418\u2013422 (2004).","journal-title":"EMBO Rep."},{"key":"BFnrmicro977_CR40","doi-asserted-by":"publisher","first-page":"25990","DOI":"10.1074\/jbc.M301232200","volume":"278","author":"S Soelaiman","year":"2003","unstructured":"Soelaiman, S. et al. Structure-based inhibitor discovery against adenylyl cyclase toxins from pathogenic bacteria that cause anthrax and whooping cough. J. Biol. Chem. 278, 25990\u201325997 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnrmicro977_CR41","doi-asserted-by":"publisher","first-page":"3242","DOI":"10.1073\/pnas.0306552101","volume":"101","author":"Y Shen","year":"2004","unstructured":"Shen, Y. et al. Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection. Proc. Natl Acad. Sci. USA 101, 3242\u20133247 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrmicro977_CR42","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.bbrc.2003.08.112","volume":"310","author":"JC Burnett","year":"2003","unstructured":"Burnett, J. C. et al. Novel small molecule inhibitors of botulinum neurotoxin A metalloprotease activity. Biochem. Biophys. Res. Commun. 310, 84\u201393 (2003).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrmicro977_CR43","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S0014-5793(98)00492-X","volume":"429","author":"M Adler","year":"1998","unstructured":"Adler, M., Nicholson, J. D., Cornille, F. & Hackley, B. E. Jr. Efficacy of a novel metalloprotease inhibitor on botulinum neurotoxin B activity. FEBS Lett. 429, 234\u2013238 (1998).","journal-title":"FEBS Lett."},{"key":"BFnrmicro977_CR44","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1006\/jmbi.1996.0865","volume":"266","author":"X Yan","year":"1997","unstructured":"Yan, X. et al. Structure-based identification of a ricin inhibitor. J. Mol. Biol. 266, 1043\u20131049 (1997).","journal-title":"J. Mol. Biol."},{"key":"BFnrmicro977_CR45","doi-asserted-by":"publisher","first-page":"30936","DOI":"10.1074\/jbc.M301154200","volume":"278","author":"MJ Rosovitz","year":"2003","unstructured":"Rosovitz, M. J. et al. Alanine-scanning mutations in domain 4 of anthrax toxin protective antigen reveal residues important for binding to the cellular receptor and to a neutralizing monoclonal antibody. J. Biol. Chem. 278, 30936\u201330944 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnrmicro977_CR46","doi-asserted-by":"publisher","first-page":"13803","DOI":"10.1073\/pnas.2436299100","volume":"100","author":"M Mourez","year":"2003","unstructured":"Mourez, M. et al. Mapping dominant-negative mutations of anthrax protective antigen by scanning mutagenesis. Proc. Natl Acad. Sci. USA 100, 13803\u201313808 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Reviews Microbiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrmicro977.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrmicro977","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrmicro977.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:44:12Z","timestamp":1684471452000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrmicro977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["BFnrmicro977"],"URL":"https:\/\/doi.org\/10.1038\/nrmicro977","relation":{},"ISSN":["1740-1526","1740-1534"],"issn-type":[{"value":"1740-1526","type":"print"},{"value":"1740-1534","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,9]]}}}